Submitted by rhiannon-arden on Fri, 04/01/2019 - 12:10
In her New Year blog, our chief executive, Clare Pelham, shares her excitement at learning of the latest scientific discoveries in the field of epilepsy from researchers at Epilepsy Society.
Submitted by rhiannon-arden on Tue, 13/11/2018 - 13:32
Epilepsy Society's Chief Executive Clare Pelham joined SUDEP Action and The Daisy Garland charity in Parliament this week to discuss service review for epilepsy and the research and implications of Brexit.
Submitted by paige-dawkins on Mon, 30/04/2018 - 15:54
Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.
Submitted by Nicola-Swanborough on Tue, 24/04/2018 - 11:44
Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in the womb.But the charity cautions that unless the regulations are backed by a public communications campaign, the long-fought-for measures may not reach those women and girls who have no option but to take the drug.
Submitted by Nicola-Swanborough on Fri, 23/03/2018 - 14:10
Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women who have ever been prescribed the epilepsy drug.'
Submitted by Nicola-Swanborough on Thu, 15/03/2018 - 13:19
The Charity Tax Commission has launched a consultation seeking views on whether and how the tax treatment of charities - estimated to be worth around £3.7bn a year - needs to be reformed.
Submitted by Nicola-Swanborough on Mon, 12/02/2018 - 17:03
New measures to avoid the exposure of unborn babies to the epilepsy drug, sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).
Submitted by Nicola-Swanborough on Tue, 09/01/2018 - 10:55
Epilepsy Society's chief executive Clare Pelham has joined the Sodium Valproate Expert Working Group which supports the Government's Commission on Human Medicines.
Submitted by Nicola-Swanborough on Mon, 08/01/2018 - 16:09
Epilepsy Society's chief executive Clare Pelham looks back over the year, at the highs and - sadly - a very snowy low.
Submitted by Nicola-Swanborough on Thu, 26/10/2017 - 13:31
Our content manager, Nicola Swanborough, explains how our sodium valproate survey helped us raise awareness of risks associated with the drug in the media, parliament and with Government.